Indoco Remedies Relieved as GST Authority Drops ₹85 Million Demand 6 days ago
The GST Authority has discontinued legal proceedings against Indoco Remedies, a major pharmaceutical company, effectively nullifying a potential demand of ₹85.00 million (₹8.50 crore). This decision removes a significant financial liability from the company's books, potentially improving its financial outlook and market perception. The resolution allows Indoco Remedies to refocus on its core business operations without the burden of ongoing GST proceedings.
Indoco Remedies Secures FDA Approval for Allopurinol Tablets May 23, 2025